Abstract
Objectives
As described recently, intravenously injected gadolinium-based contrast agent (GBCA) penetrates into the anterior eye chamber (AC) and is drained from the retina to the distal optic nerve (ON) along perivascular spaces, which serves retinal homeostasis and was termed the orbital glymphatic system (GS). Independently, AC enhancement predicted ON infiltration, a major risk factor for advanced retinoblastoma (RB), in a small RB patient cohort. We aimed to review the supposed imaging biomarker for ON infiltration in a large RB cohort and with respect to the recently described orbital GS.
Methods
This IRB–approved retrospective single-center study encompassed 539 orbital MRIs performed with an orbital coil and with the children under general anesthesia. Differences of signal intensity ratios (∆SIRs) of the AC to the lens were determined between non-contrast and GBCA–enhanced T1-weighted images and were correlated with histopathologic presence of ON infiltration.
Results
∆SIR of the RB eye was an independent, significant predictor for ON invasion in multivariate analysis with adjustment for tumor size (p < 0.05) and increased with infiltration level.
Conclusions
GBCA enhancement of the AC predicts ON infiltration. This might be caused by impairment of the orbital glymphatic system, which is supposed to clear toxic metabolites from the retina to the postlaminar ON. In RB with ON infiltration, this efflux path is likely to be inhibited, which is supposed to result in disturbed retinal homeostasis, release of vascular endothelial growth factor, and iris neovascularization, which increases penetration of GBCA into the AC.
Key Points
• Infiltration of the optic nerve can be predicted by anterior chamber enhancement after intravenous MRI contrast agent administration.
• Increased anterior chamber enhancement in retinoblastoma with optic nerve infiltration might result from dysfunction of the orbital glymphatic system with disturbance of retinal homeostasis and consecutive iris neovascularization.
Supplementary Information
The online version contains supplementary material available at 10.1007/s00330-022-08778-4.
Keywords: Gadolinium, Retinoblastoma, Glymphatic system, Optic nerve, Magnetic resonance imaging
Introduction
In children suffering from retinoblastoma (RB), optic nerve (ON) infiltration is a major risk factor for advanced disease [1, 2]. As RB are “no-touch lesions,” due to the high risk of tumor seeding, therapy is initiated without previous histological examination and pretreatment staging MRI plays a key role in the diagnostic workup of RB. Orbital MRI needs to identify risk factors of advanced disease such as ON infiltration as they guide therapy decisions. Specifically, while bulb enucleation remains the principal therapy, vision-preserving therapy is highly desirable in the very early disease stage [3]. Furthermore, knowledge on ON infiltration determines the security margin with which the distal ON is resected when enucleation has to be performed [4]. Hence, it is essential for pretreatment MRI to identify ON infiltration, but the diagnostic accuracy is highly variable, with reported sensitivities ranging from 50 to 73% [5–11].
Recently, a correlation between ON infiltration and gadolinium-based contrast agent (GBCA) enhancement of the anterior eye chamber was reported in a small cohort of RB patients [12].
The orbital glymphatic system functions in accordance to the glymphatic system of the brain and mediates perivascular clearance of toxic metabolites from the retina to the distal ON to maintain retinal homeostasis [13]. Disturbance of retinal homeostasis is known to result in neovascular glaucoma and iris neovascularization [14–16], which might explain the observed increase of GBCA penetration into the AC in RB with ON infiltration reported by Galluzzi et al. Consistently, it was reported that AC enhancement was accompanied by the presence of neovascular processes of the anterior eye segment [5, 12, 17].
While it is known that the orbital glymphatic pathway can be visualized with GBCA–enhanced heavily T2-weighted (hT2) MRI, which is highly sensitive to GBCAs in fluids [18–21], standard T1-weighting usually does not reveal the small amount of GBCA crossing the blood-ocular barrier after intravenous injection. However, in this study, we consulted a large RB cohort that was investigated with bilateral orbital coils under anesthesia. In this specific setting, which allows for high-resolution T1-weighting with suppression of eye motion artifacts and provides T1-weighting with identical sequence parameters prior to and following GBCA injection, T1-weighting was previously shown to reveal the slight signal increase caused by intravenously injected GBCA penetrating into the AC of healthy eyes [22].
In this study, we aimed to review the suggested imaging biomarker of ON infiltration in a large cohort of a national RB center and put results into context of the recently described orbital glymphatic system.
Patients and methods
Patients
Written informed consent was waived due to the retrospective character of this IRB–approved study. All initial orbital MRI of patients suspicious of RB which were performed at our institution between September 2010 and June 2019 were reviewed (n = 586). MRI were excluded if therapy had already started, any GBCA injection had been performed within 8 weeks prior to the respective orbital MRI, or insufficient image quality impeded image analysis, e.g., due to motion artifacts. Finally, 539 orbital MRI were included, 356 of RB eyes and 183 of healthy eyes. The flow chart in Fig. 1 presents the number of included orbital MRI with inclusion and exclusion criteria. Two examples of orbital MRI are provided in Fig. 2.
MRI protocol
All patients were assessed at the same 1.5-T MRI scanner (MAGNETOM Aera, Siemens Healthineers) using a 4-cm loop coil. Identical T1-weighted images (repetition time 583 ms, echo time 16 ms, flip angle 90°, voxel size 0.2 × 0.2 × 2.0 mm, field of view (FoV) read 80 mm, FoV phase 131.3%, 20 slices, distance factor 20%, acquisition time 7:53 min) were obtained prior to and 12:21 ± 2:36 minutes (mean ± standard deviation (SD)) post injection of a standard dose of gadoterate dimeglumine (0.1 ml/kg body weight). MRI was performed with the children in a state of general anesthesia induced by propofol (1 ml/kg body weight, 1%).
For 47 RB eyes in 38 children, signal intensity ratios (SIRs) were calculated from T1-weighted images with and without active prescan normalization to assess the influence of prescan normalization on SIRs.
Image analysis
Every case was assessed by either of two readers with 1 and 3 years of experience in neuroradiology, who conducted image analysis on an accredited workstation after a pre-reading session with teaching by a neuroradiologist with 10 years of experience.
Signal intensities (SIs) of the AC and lens were extracted via region-of-interest (ROI) measurements with ROIs drawn in the AC and lens on the most representative axial slice (supplementary fig. e-1).
The difference in AC-to-lens SIR (∆SIR) between pre- and post-GBCA–enhanced scans was determined as follows:
Tumor size was classified with a 6-point ordinal scale on the basis of the axial plane with the most prominent tumor presence. Affection of the entire globe was scored as a 6 (supplementary fig. e-2). If tumor expansion on the sagittal plane suggested a substantially different score, the score was adapted. Histopathology of enucleated RB eyes was assessed by chart review.
Statistical analysis
Statistical analysis was performed with the software package R (R Foundation for Statistical Computing, version 3.5.2, 2018-12-20). Significance was set at the p < 0.05 level. Mann-Whitney U test was performed to compare ∆SIRs of healthy and RB eyes, as well as ∆SIRs of different ON infiltration levels. Wilcoxon test was conducted to compare pre- and post-contrast SIRs.
Multivariate logistic regression with adjustment for tumor size was performed to investigate if ∆SIR can predict histopathological tumor features. Logistic regression was chosen, because we aimed to not only correlate ∆SIR and histopathology, but also to investigate the value of ∆SIR in predicting a dichotomous target variable, i.e., presence or absence of histopathological infiltration. As only ∆SIR but not the target variable, i.e., ON infiltration status, depends on patient age and post-injection (p.i.) time, age and p.i. time were not taken into account as confounders.
Results
Patient characteristics
Patient characteristics are summarized in Table 1. Five hundred thirty-nine orbital MRI of 270 consecutive treatment-naïve patients with uni- or bilateral RB were included in the study. Analysis encompassed 356 eyes harboring RB and 183 healthy eyes in 183 children with unilateral (67.8%) and 87 patients with bilateral RB (32.2%). In one case of bilateral RB, only one RB eye could be assessed as the other one had already been enucleated. The healthy eyes of patients with unilateral RB were part of a previously published study about GBCA dynamics in healthy infantile eyes. Average age (range) of the patients was 18.9 (0–91) months. One hundred seventeen girls (43.3%) and 153 boys (56.7%) were included. Mean (range) serum creatinine level was 0.43 (0.19–0.77) mg/dl. The International Classification of Retinoblastoma (ICRB) score was extracted from the tumor board documentation, if available (available for 322 of 356 RB eyes; results are presented in Table 1). Two hundred five of 356 RB eyes were enucleated (57.6%); for 201 of 205 enucleated eyes, a histopathology report could be extracted from the clinical documentation system (compare Fig. 1).
Table 1.
Characteristic | Number |
---|---|
Patients | |
Total | 270 |
With unilateral RB | 183 |
With bilateral RB | 87 |
Orbital MRI | |
Total | 539 |
With RB | 3561 |
From unilateral RB | 183 |
From bilateral RB | 1731 |
Without RB (i.e., from unilateral RB) |
183 |
Age [months], mean (range) | 18.9 (0.0–91.0) |
Gender [female %] | 43.3% |
Serum creatinine [mg/dl] mean (range) | 0.43 (0.19–0.77) |
ICRB score2 | |
Group A | 16 |
Group B | 71 |
Group C | 13 |
Group D | 47 |
Group E | 175 |
NA | 34 |
ON infiltration | |
No | 94 (46.8%) |
Prelaminar | 73 (36.3%) |
Laminar | 20 (10.0%) |
Postlaminar | 14 (7.0%) |
Central vessel infiltration | |
Yes | 2 (1.0%) |
No | 198 |
NA | 1 |
ICRB International Classification of Retinoblastoma, RB retinoblastoma, ON optic nerve
1Of one patient with bilateral RB, only one RB was included, because the other eye had already been enucleated
2ICRB score was taken from the tumor board documentation
Comparison of AC-to-lens SIRs
SIRs derived from scans with and without active prescan normalization showed a strong linear correlation (rPearson > 0.99, p < 0.001, supplementary fig. e-3). Therefore, assessment of orbital MRI with active prescan normalization was deemed to be valid.
Median SIR of contrast-enhanced scans was significantly greater than that of native scans in RB eyes (median SIRpre (IQR) = 76.8 (63.5–92.1), median SIRpost (IQR) = 105.8 (82.5–170.4), Wilcoxon test, p < 0.001). SIRs and ∆SIRs are presented in Table 2.
Table 2.
Median | Interquartile range (IQR) | p value | |
---|---|---|---|
SIRpre | 76.8 | 63.5–92.1 | < 0.001 |
SIRpost | 105.8 | 82.5–170.4 | |
∆SIRRB | 0.23 | 0.10–0.60 | < 0.001 |
∆SIRhealthy | 0.08 | 0.05–0.13 | |
∆SIRRB, ON infiltration | |||
Yes (n = 107) | 0.62 | 0.18–1.21 | 0.001 |
No (n = 94) | 0.27 | 0.12–0.52 | |
∆SIRRB, ON infiltration | |||
None (n = 94) | 0.27 | 0.12–0.52 | – |
Prelaminar (n = 73) | 0.50 | 0.14–1.13 | 0.03 |
Laminar (n = 20) | 0.62 | 0.27–1.32 | 0.004 |
Postlaminar (n = 14) | 0.85 | 0.50–1.22 | 0.01 |
∆SIRRB, ON infiltration | |||
None + prelaminar | 0.35 | 0.12–0.91 | – |
Postlaminar | 0.85 | 0.50–1.22 | 0.06 |
∆SIR differences of signal intensity ratios of the anterior chamber to the lens, SIR signal intensity ratios of the anterior chamber to the lens, SIRpre SIR prior to contrast agent injection, SIRpost SIR post contrast agent injection, RB retinoblastoma, ON optic nerve
Comparison of AC-to-lens signal intensity ratio differences
Median ∆SIR of RB eyes was significantly greater as compared to that of healthy eyes (median ∆SIRRB (IQR) = 0.23 (0.10–0.60), median ∆SIRhealthy (IQR) = 0.08 (0.05–0.13), Mann-Whitney U test, p < 0.001).
Figure 2 presents examples of the different MRI sequences of the orbital MRI protocol that allow for comparison of native and GBCA–enhanced ACs as well as of RB and healthy eyes in a patient with prelaminar and a patient with postlaminar ON infiltration. Histograms comparing SIRs and ∆SIRs are presented in Fig. 3.
Qualitative assessment of the AC revealed a slightly visible SI increase adjacent to the ventral iris with a maximum in the iridocorneal angle in 238 of 356 RB eyes (66.9%) and 38 of 183 (20.8%) healthy eyes (Fig. 2(I + J), and supplementary fig. e-1F).
Correlation of AC enhancement and ON infiltration
In 201 of 205 enucleated eyes, histopathology with information about ON infiltration was available. One hundred seven RBs depicted ON involvement (53.2%). Median ∆SIR in RB eyes with ON involvement was significantly greater than that of RB eyes without ON infiltration (p = 0.001).
Seventy-three RBs showed prelaminar (36.3), 20 laminar (10.0%), and 14 postlaminar (7.0%) infiltration of the ON. Degree of AC enhancement increased with ON infiltration level with a significantly higher median ∆SIR of prelaminar ON infiltration compared to absence of ON infiltration (p = 0.03, Fig. 4(B)). Furthermore, median ∆SIR of RB eyes with postlaminar ON involvement was compared to that of all RB eyes with either no or prelaminar ON infiltration (p = 0.06).
Multivariate logistic regression with adjustment for tumor size revealed that ∆SIR was an independent positive predictor for ON invasion with doubled infiltration risk per unit change of ∆SIR (OR∆SIR (IQR) = 1.9 (1.1–3.6), p∆SIR = 0.03). In turn, with a maximum observed ∆SIR of 2.6, this patient’s risk for optic infiltration was five times as high as the risk of the patient with the lowest observed ∆SIR of zero.
In addition, tumor size was a significant predictor for ON infiltration (ORtumor size (IQR) = 1.3 (1.0–1.6), ptumor size = 0.04).
Discussion
The current study revealed that the degree of GBCA enhancement in the anterior eye chamber is predictive for optic nerve infiltration—one of the major risk factors for advanced disease in children suffering from retinoblastoma.
This might prospectively be exploited as a diagnostic imaging biomarker and serves as an example of how knowledge about the cerebral excretion pathway of GBCAs might yield diagnostic value.
The orbital glymphatic system
While AC hyperintensity has been recognized in patients with RB before, studies on brain clearance imaging revealed that GBCAs penetrate into the AC physiologically and questioned the value of AC hyperintensity as a potential imaging biomarker [5, 12, 19, 22]. Furthermore, AC enhancement of the healthy eye is accompanied by enhancement of the vitreous and of the subarachnoid space (SAS) surrounding the postlaminar ON on heavily T2-weighted FLAIR MRI 3 h post GBCA injection (Fig. 5) [19]. Accordingly, apart from uveoscleral drainage and outflow via the Schlemm’s canal, recently, an additional posterior efflux pathway of intraocular fluid into the postlaminar ON was suggested, which is supposed to be mediated by the trans-laminar cribrosa pressure difference (TLCPD) [13, 23]. This posterior efflux path of ocular fluid was shown to follow the principles of the glymphatic system and therefore termed the orbital glymphatic system. Intravitreal injection of fluorescent tracers was followed by perivascular enhancement of vessels in both the retina as well as ON, and communication between perivascular spaces within the ON and the SAS surrounding the ON was reported [23]. Finally, reabsorption of CSF tracer from the SAS of the ON is supposed to be carried out by meningeal lymphatics located in the dura ensheathing the ON [24–26].
In analogy to the brain glymphatic system, which mediates interstitial-fluid / cerebrospinal-fluid (CSF) exchange and serves waste clearance from the brain, ocular-fluid / CSF exchange serves nutritional function and metabolite clearance from the retina. As the retina is one of the most metabolically active tissues in the human body, orbital glymphatic function might be crucial to maintain retinal homeostasis and function.
We hypothesize that the correlation between AC enhancement and ON infiltration is caused by orbital glymphatic dysfunction due to reduced trans-laminar glymphatic flow caused by the tumor (Fig. 6): Glymphatic insufficiency might result in retinal accumulation of toxic metabolites and reduced nutrient supply. Disturbance of retinal homeostasis is known to cause release of vascular endothelial growth factor (VEGF) with consecutive neoangiogenesis including the iris. Neovascularization notoriously increases vessel permeability with subsequently increased penetration of GBCA into the AC following intravenous injection.
Remarkably, ON infiltration is known to be associated with increased intraocular pressure (IOP) [17], which might result from iris neovascularization with concomitant neovascular glaucoma.
Diagnostic implication in RB
Today, if localized disease can be confirmed, RB may be treated conservatively to retain the child’s vision [3]. Therefore, initial staging aims to classify RB with respect to the predicted salvage rate of the eye with 13% of the enucleated group D eyes revealing high-risk histopathology [27, 28]. Therein, ON infiltration is a major risk factor for advanced disease with a 13% 5-year metastatic risk in patients with postlaminar ON involvement and a significant reduction in overall survival with ON infiltration depth [1, 2].
Therefore, pretreatment MRI is supposed to identify ON infiltration; however, diagnostic accuracy of MRI findings is known to be limited [5–10].
While the here-reported semiquantitative signal intensity ratio differences do not allow for calculation of a cut-off for discrimination between RB eyes with regard to ON infiltration, future studies might investigate direct imaging of the orbital GBCA distribution following intravenous injection, e.g., with heavily T2-weighted FLAIR MRI [29].
Remarkably, GBCA enhancement increased gradually with infiltration level and was greater in RB with postlaminar compared to a combined group of RB with either none or prelaminar ON infiltration (p = 0.06). This might be of diagnostic importance as the prognostic effect of the different ON infiltration levels remains unclear with some studies suggesting that the prognostic impact of ON infiltration might be confined to postlaminar involvement, but might not exist for prelaminar ON infiltration [1, 2].
Strengths and limitations of this study need to be acknowledged. An obvious strength of the study is the large patient cohort, the histopathology reference, and the high-resolution orbital MRI of RB as well as healthy eyes obtained with surface coils and identical sequence parameters in children under general anesthesia.
However, a final explanation for the here-introduced phenomenon cannot be concluded and the physiology of the interrelation between AC enhancement and ON infiltration remains uncertain.
Furthermore, disturbance of retinal homeostasis with consecutive neovascularization of the iris might be caused by impeded arterial perfusion / venous drainage due to affection of the central vein or artery by the tumor. However, histologic assessment revealed vascular infiltration in only two RB eyes, both of them with low ∆SIR and only one with (prelaminar) optic infiltration.
In conclusion, this study revealed a surprising link between GBCA enhancement in the anterior eye chamber and optic nerve infiltration by the retinoblastoma, which might be explained by orbital glymphatic dysfunction and serves as an example of how cerebral GBCA excretion adds diagnostic information on neurological pathologies.
Supplementary information
Abbreviations
- ∆SIR
Difference in AC-to-lens SIR
- AC
Anterior chamber
- CSF
Cerebrospinal fluid
- FoV
Field of view
- GBCA
Gadolinium-based contrast agent
- IOP
Intraocular pressure
- IQR
Interquartile range
- OD
Odds ratio
- ON
Optic nerve
- p.i.
Post injection
- RB
Retinoblastoma
- ROI
Region of interest
- SAS
Subarachnoid space
- SD
Standard deviation
- SI
Signal intensity
- SIR
Signal intensity ratio
- TLCPD
Trans-laminar cribrosa pressure difference
Funding
Open Access funding enabled and organized by Projekt DEAL.
Declarations
Guarantor
The scientific guarantor of this publication is Katerina Deike-Hofmann.
Conflict of interest
The authors of this manuscript declare relationships with the following companies: K. Deike-Hofmann: lecture payment by GE, financial study support: Bayer AG, Guerbet; A. Radbruch: personal fees for consulting and talks (within the last 3 years): Bayer, Guerbet, Novartis; financial study support: Bayer, Guerbet.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was waived by the Institutional Review Board.
Ethics approval
Institutional review board approval was obtained.
Study subjects or cohorts overlap
Some study subjects or cohorts have been previously reported in Deike-Hofmann et al, The anterior eye chamber: entry of the natural excretion pathway of gadolinium contrast agents? Eur Radiol, 2020.
Methodology
• retrospective
• diagnostic or prognostic study
• performed at one institution
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Shields C, Shields JA, Baez K, Cater IR, De P. Optic nerve invasion of retinoblastoma metastatic potential and clinical risk factors. Cancer. 1993;73(3):692–698. doi: 10.1002/1097-0142(19940201)73:3<692::AID-CNCR2820730331>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
- 2.Messmer EP, Heinrich T, Höpping W, de Sutter E, Havers W, Sauerwein W. Risk factors for metastases in patents with retinoblastoma. Ophthalmology. 1991;98(2):136–141. doi: 10.1016/S0161-6420(91)32325-X. [DOI] [PubMed] [Google Scholar]
- 3.MacCarthy A, Birch JM, Draper GJ, et al. Retinoblastoma: treatment and survival in Great Britain 1963 to 2002. Br J Ophthalmol. 2009;93(1):38–39. doi: 10.1136/bjo.2008.139626. [DOI] [PubMed] [Google Scholar]
- 4.Chintagumpala M, Chevez-Barrios P, Paysse EA, Plon SE, Hurwitz R. Retinoblastoma: review of current management. Oncologist. 2007;12(10):1237–1246. doi: 10.1634/theoncologist.12-10-1237. [DOI] [PubMed] [Google Scholar]
- 5.De Graaf P, Barkhof F, Moll AC, et al. Retinoblastoma: MR imaging parameters in detection of tumor extent. Radiology. 2005;235(1):197–207. doi: 10.1148/radiol.2351031301. [DOI] [PubMed] [Google Scholar]
- 6.de Graaf P, Moll A, Imhof S, von der Valk M, Castelijns JA. Retinoblastoma and optic nerve enhancement on MRI: not always extraocular tumour extension. Br J Ophthalmol. 2006;90(6):800–801. doi: 10.1136/bjo.2006.092361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Schueler AO, Hosten N, Bechrakis NE, et al. High resolution magnetic resonance imaging of retinoblastoma. Br J Ophthalmol. 2003;87(3):330–335. doi: 10.1136/bjo.87.3.330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Song KD, Eo H, Kim JH, Yoo SY, Jeon TY. Can preoperative MR imaging predict optic nerve invasion of retinoblastoma? Eur J Radiol. 2012;81(12):4041–4045. doi: 10.1016/j.ejrad.2012.03.034. [DOI] [PubMed] [Google Scholar]
- 9.Li Z, Guo J, Xu X, Wang Y, Mukherji SK, Xian J. Diagnosis of postlaminar optic nerve invasion in retinoblastoma with MRI features. J Magn Reson Imaging. 2020;51(4):1045–1052. doi: 10.1002/jmri.26961. [DOI] [PubMed] [Google Scholar]
- 10.Cui Y, Luo R, Wang R, et al. Correlation between conventional MR imaging combined with diffusion-weighted imaging and histopathologic findings in eyes primarily enucleated for advanced retinoblastoma: a retrospective study. Eur Radiol. 2018;28(2):620–629. doi: 10.1007/s00330-017-4993-7. [DOI] [PubMed] [Google Scholar]
- 11.Kim U, Rathi G, Chowdhary G, Srinavasan KG, Shanthi R, Krishna RSP. Accuracy of preoperative imaging in predicting optic nerve invasion in retinoblastoma: a retrospective study. Indian J Ophthalmol. 2019;67(12):2019–2022. doi: 10.4103/ijo.IJO_1611_18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Galluzzi P, Cerase A, Hadjistilianou T, et al. Retinoblastoma: abnormal gadolinium enhancement of anterior segment of eyes at MR imaging with clinical and histopathologic correlation. Radiology. 2003;228(3):683–690. doi: 10.1148/radiol.2283020466. [DOI] [PubMed] [Google Scholar]
- 13.Wang X, Lou N, Eberhardt A, et al. An ocular glymphatic clearance system removes beta-amyloid from the rodent eye. Sci Transl Med. 2020;12:3210–3224. doi: 10.1126/scitranslmed.aaw3210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Senthil S, Dada T, Das T, et al. Neovascular glaucoma-a review. Indian J Ophthalmol. 2021;69(3):525–534. doi: 10.4103/ijo.IJO_1591_20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Rodrigues GB, Abe RY, Zangalli C et al (2016) Neovascular glaucoma: a review. Int J Retin Vitr 2(1). 10.1186/s40942-016-0051-x [DOI] [PMC free article] [PubMed]
- 16.Beutel J, Peters S, Lüke M, et al. Bevacizumab as adjuvant for neovascular glaucoma. Acta Ophthalmol. 2010;88(1):103–109. doi: 10.1111/j.1755-3768.2008.01355.x. [DOI] [PubMed] [Google Scholar]
- 17.Chawla B, Sharma S, Sen S, et al. Correlation between clinical features, magnetic resonance imaging, and histopathologic findings in retinoblastoma: a prospective study. Ophthalmology. 2012;119(4):850–856. doi: 10.1016/j.ophtha.2011.09.037. [DOI] [PubMed] [Google Scholar]
- 18.Naganawa S, Yamazaki M, Kawai H, Sone M, Nakashima T. Contrast enhancement of the anterior eye segment and subarachnoid space: detection in the normal state by heavily T 2 -weighted 3D FLAIR. Magn Reson Med Sci. 2011;10(3):193–199. doi: 10.2463/mrms.10.193. [DOI] [PubMed] [Google Scholar]
- 19.Deike-Hofmann K, Reuter J, Haase R, et al. Glymphatic pathway of gadolinium-based contrast agents through the brain: overlooked and misinterpreted. Invest Radiol. 2019;54(4):229–237. doi: 10.1097/RLI.0000000000000533. [DOI] [PubMed] [Google Scholar]
- 20.Jost G, Frenzel T, Lohrke J, Lenhard DC, Naganawa S, Pietsch H. Penetration and distribution of gadolinium-based contrast agents into the cerebrospinal fluid in healthy rats: a potential pathway of entry into the brain tissue. Eur Radiol. 2017;27(7):2877–2885. doi: 10.1007/s00330-016-4654-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Taoka T, Jost G, Frenzel T, Naganawa S, Pietsch H. Impact of the glymphatic system on the kinetic and distribution of gadodiamide in the rat brain: observations by dynamic MRI and effect of circadian rhythm on tissue gadolinium concentrations. Invest Radiol. 2018;53:529–534. doi: 10.1097/RLI.0000000000000473. [DOI] [PubMed] [Google Scholar]
- 22.Deike-Hofmann K, von Lampe P, Schlemmer H, et al. The anterior chamber of the eye: an overlooked entry of the natural excretion pathway of gadolinium based contrast agents? Eur Radiol. 2020;30:4633–4640. doi: 10.1007/s00330-020-06762-4. [DOI] [PubMed] [Google Scholar]
- 23.Mathieu E, Gupta N, Ahari A, Zhou X, Hanna J, Yücel YH. Evidence for cerebrospinal fluid entry into the optic nerve via a glymphatic pathway. Investig Ophthalmol Vis Sci. 2017;58(11):4784–4791. doi: 10.1167/iovs.17-22290. [DOI] [PubMed] [Google Scholar]
- 24.Killer HE, Jaggi GP, Flammer J, Miller NR, Huber AR, Mironov A. Cerebrospinal fluid dynamics between the intracranial and the subarachnoid space of the optic nerve. Is it always bidirectional? Brain. 2007;130(2):514–520. doi: 10.1093/brain/awl324. [DOI] [PubMed] [Google Scholar]
- 25.Killer HE (2013) Production and circulation of cerebrospinal fluid with respect to the subarachnoid space of the optic nerve. J Glaucoma 22. 10.1097/IJG.0b013e318293498b [DOI] [PubMed]
- 26.Killer HE, Laeng H, Groscurth P (1999) Lymphatic capillaries in the meninges of the human optic nerve. J Neuroophthalmol. 19(4):222–228 [PubMed]
- 27.Shields CL, Mashayekhi A, Au AK, et al. The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology. 2006;113(12):2276–2280. doi: 10.1016/j.ophtha.2006.06.018. [DOI] [PubMed] [Google Scholar]
- 28.Fabian ID, Stacey AW, Chowdhury T, et al. High-risk histopathology features in primary and secondary enucleated International Intraocular Retinoblastoma Classification Group D Eyes. Ophthalmology. 2017;124(6):851–858. doi: 10.1016/j.ophtha.2017.01.048. [DOI] [PubMed] [Google Scholar]
- 29.Mijnders LS, Steup FW, Lindhout M, Kleij PA van der Brink WM, van der Molen AJ (2020) Optimal sequences and sequence parameters for GBCA-enhanced MRI of the glymphatic system: a systematic literature review. Acta radiol. Published online November 5, 028418512096995. 10.1177/0284185120969950 [DOI] [PubMed]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.